Long-acting systemic GLP-1 analogs (liraglutide, semaglutide) are obtained by reversibly binding to albumin
Titration matters: Both medications start at low doses and increase gradually
According to Couture Med Spa, citing a New England Journal of Medicine trial, tirzepatide users can lose up to 15% of their body weight over 18 months, a result the practice attributes to the peptide's dual action on GIP and GLP-1 receptors
Parker VE, Robertson D, Wang T, Hornigold DC, Petrone M, Cooper AT, et al
Tsapas A, Avgerinos I, Karagiannis T et al (2020) Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis
Understanding when and why fatigue occurs can help patients manage it effectively and avoid unnecessary concerns